Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
Screenshot of PathAI's AIM-MASH AI Assist in action. An artificial intelligence model developed by PathAI – used to help diagnose metabolic dysfunction associated steatohepatitis (MASH) from liver ...
Teenagers Scott and Mary are on their way to a Halloween party when their car breaks down, and they encounter a creepy castle where the depraved Dr. Frankenstein seeks to put Scott's brain in his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback